Specification BPC-157 TB-500 (Thymosin Beta-4) Cartalax (AED) Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser Ala-Glu-Asp Molecular Formula C62H98N16O22 C212H350N56O78S C12H19N3O8 Molecular Weight 1419.5 g/mol 4963.4 g/mol 333.29 g/mol CAS Number 137525-51-0 77591-33-4 205640-90-0 PubChem CID 9941957 16132341 87815447 Synonyms Bepecin, Bpc 15, Body protection compound 15, Pentadecapeptide Thymosin Beta 4, Thymosin 4, TB500, Timbetasin T-31, AED, Alanyl-glutamyl-aspartic acid
never reuse a needle between vials
Some people feel slightly better within a few days, while others notice gradual improvement over one to two weeks
Research Use Notice BPC-157 is provided strictly for laboratory research and development purposes
The connection to semaglutide treatment is indirect but real
No studies have used actual ADHD models or tested attention, hyperactivity, or impulsivity in relevant paradigms
